Data on biopharma deal-making in 2015
Biopharma deal-making in 2015 featured substantial consolidation and bigger transaction values than ever.
Biopharma deal-making in 2015. a | Mergers and acquisitions (M&As). The chart includes full-company acquisitions and purchases of majority stakes. The 'number of deals' total includes deals that did not have a disclosed value. b | Partnerships. c | Breakdown of partnerships by therapeutic area. Deals involving more than one therapy area may be counted multiple times, if applicable. Source: Medtrack.
Source article: Micklus, A. & Muntner, S. Biopharma deal-making in 2015: changing the pharma landscape. Nature Reviews Drug Discovery 15,78–79 (2016) http://www.nature.com/nrd/journal/v15/n2/full/nrd....